Windtree Therapeutics, Inc. (WINT) earnings
WINT earnings moved a median of -1.44% by the close. Quarterly and annual WINT reports and results, each read against the price at its own news timestamp. Back to the WINT overview →
20 measured WINT earnings events.
Where these WINT earnings landedvs 20 measured WINT earnings reactions
| Middle 50% of WINT earnings reactions | -5.58% to +0.11% |
|---|---|
| Median reaction (to close) | -1.44% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 WINT earnings events with a measured close landed between -5.58% and +0.11%; 25% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form NT 10-K WINDTREE THERAPEUTICS For: Dec 31 | SEC filing · Form NT | — | -16.00% | |
| Form 10-Q WINDTREE THERAPEUTICS For: Sep 30 | SEC filing · Form 10-Q | +9.90% | +0.80% | |
| Form NT 10-Q WINDTREE THERAPEUTICS For: Sep 30 | SEC filing · Form NT | +3.50% | +0.00% | |
| Form 10-Q WINDTREE THERAPEUTICS For: Jun 30 | SEC filing · Form 10-Q | +0.96% | -77.10% | |
| Form NT 10-Q WINDTREE THERAPEUTICS For: Jun 30 | SEC filing · Form NT | +0.72% | +0.43% | |
| Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates | Press release | +1.21% | -0.24% | |
| Form 10-Q WINDTREE THERAPEUTICS For: Mar 31 | SEC filing · Form 10-Q | +1.21% | -0.24% | |
| Form 10-K WINDTREE THERAPEUTICS For: Dec 31 | SEC filing · Form 10-K | -0.91% | -1.74% | |
| Form NT 10-K WINDTREE THERAPEUTICS For: Dec 31 | SEC filing · Form NT | +0.75% | -7.69% | |
| Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates | Press release | -23.33% | -11.58% | |
| Form 10-Q WINDTREE THERAPEUTICS For: Sep 30 | SEC filing · Form 10-Q | -0.55% | +10.87% | |
| Form NT 10-Q WINDTREE THERAPEUTICS For: Sep 30 | SEC filing · Form NT | -4.33% | -3.01% | |
| Windtree Therapeutics Reports Second Quarter 2024 Financial Results and Provides Key Business Updates | Press release | -0.25% | -5.89% | |
| Form 10-Q WINDTREE THERAPEUTICS For: Jun 30 | SEC filing · Form 10-Q | -2.36% | -5.48% | |
| Form NT 10-Q WINDTREE THERAPEUTICS For: Jun 30 | SEC filing · Form NT | +0.00% | +8.21% | |
| Form 10-Q WINDTREE THERAPEUTICS For: Mar 31 | SEC filing · Form 10-Q | -0.89% | -4.66% | |
| Form 10-K WINDTREE THERAPEUTICS For: Dec 31 | SEC filing · Form 10-K | +0.00% | -4.18% | |
| Form NT 10-K WINDTREE THERAPEUTICS For: Dec 31 | SEC filing · Form NT | -2.37% | +8.57% | |
| Form 10-Q WINDTREE THERAPEUTICS For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -1.14% | |
| Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates | Press release | +0.00% | -1.14% |
Keep exploring
More WINT: analyst actions → · SEC filings → · WINT overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Corvus Pharmaceuticals, Inc. (CRVS) | 208 | -0.32% | 48% |
| Journey Medical Corporation (DERM) | 208 | 0.00% | 50% |
| Cronos Group Inc (CRON_TSE) | 206 | +0.15% | 50% |
| Pediatrix Medical Group, Inc. (MD) | 206 | +0.02% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.